Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ADP-ribosylation is involved in a variety of biological processes, many of which are chromatin-dependent and linked to important functions during the cell cycle. However, any study on ADP-ribosylation and the cell cycle faces the problem that synchronization with chemical agents or by serum
starvation
and subsequent growth factor addition already activates ADP-ribosylation by itself. Here, we investigated the functional contribution of ARTD1 in cell cycle re-entry and G1/S cell cycle progression using T24 urinary bladder carcinoma cells, which synchronously re-enter the cell cycle after splitting without any additional stimuli. In synchronized cells, ARTD1 knockdown, but not inhibition of its enzymatic activity, caused specific down-regulation of
cyclin E
during cell cycle re-entry and G1/S progression through alterations of the chromatin composition and histone acetylation, but not of other E2F-1 target genes. Although Cdk2 formed a functional complex with the residual
cyclin E
, p27(Kip 1) protein levels increased in G1 upon ARTD1 knockdown most likely due to inappropriate
cyclin E
-Cdk2-induced phosphorylation-dependent degradation, leading to decelerated G1/S progression. These results provide evidence that ARTD1 regulates cell cycle re-entry and G1/S progression via
cyclin E
expression and p27(Kip 1) stability independently of its enzymatic activity, uncovering a novel cell cycle regulatory mechanism.
...
PMID:ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells. 2729 4
The tumor microenvironment is characterized by nutrient-deprived conditions in which the cancer cells have to adapt for survival. Serum
starvation
resembles the growth factor deprivation characteristic of the poorly vascularized tumor microenvironment and has aided in the discovery of key growth regulatory genes and microRNAs (miRNAs) that have a role in the oncogenic transformation. We report here that miR-874 down-regulates the major G
1
/S phase cyclin,
cyclin E1
(
CCNE1
), during serum
starvation
. Because the adaptation of cancer cells to the tumor microenvironment is vital for subsequent oncogenesis, we tested for miR-874 and
CCNE1
interdependence in osteosarcoma cells. We observed that miR-874 inhibits
CCNE1
expression in primary osteoblasts, but in aggressive osteosarcomas, miR-874 is down-regulated, leading to elevated
CCNE1
expression and appearance of cancer-associated phenotypes. We established that loss of miR-874-mediated control of
cyclin E1
is a general feature of osteosarcomas. The down-regulation of
CCNE1
by miR-874 is independent of E2F transcription factors. Restoration of miR-874 expression impeded S phase progression, suppressing aggressive growth phenotypes, such as cell invasion, migration, and xenograft tumors, in nude mice. In summary, we report that miR-874 inhibits
CCNE1
expression during growth factor deprivation and that miR-874 down-regulation in osteosarcomas leads to
CCNE1
up-regulation and more aggressive growth phenotypes.
...
PMID:MicroRNA-874-mediated inhibition of the major G
1
/S phase cyclin, CCNE1, is lost in osteosarcomas. 2910 43
<< Previous
1
2
3
4
5